In a significant policy move, President Donald Trump has signed an executive order that prohibits federal support for gender-affirming medical treatments for individuals under the age of 19. The order, titled "Protecting Children from Chemical and Surgical Mutilation," was signed on January 28, 2025, and directs federal agencies to cease funding, sponsoring, promoting, assisting, or supporting gender transition procedures for minors.
The executive order specifically targets medical interventions such as puberty blockers, hormone therapies, and gender-affirming surgeries for transgender youth. It mandates that federal insurance programs, including Medicaid. . .